Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms

BACKGROUND: Guaifenesin is a component of medicines used to improve symptoms associated with upper respiratory tract infections. Patient-reported outcome instruments are valuable for evaluating symptom improvements; however, a validated tool to assess efficacy of mucoactive drugs does not exist. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Helmut, Vernon, Margaret, Solomon, Gail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546880/
https://www.ncbi.nlm.nih.gov/pubmed/23270519
http://dx.doi.org/10.1186/1465-9921-13-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546880/
https://www.ncbi.nlm.nih.gov/pubmed/23270519
http://dx.doi.org/10.1186/1465-9921-13-118

Ejemplares similares